Antibiotics for community-acquired pneumonia

Matthew Dryden, Kieran Hand, Peter Davey, BSAC Council, Laura Piddock

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Antibiotic guidelines for community-acquired pneumonia (CAP) often recommend broad-spectrum agents for severe pneumonia. While these may be entirely appropriate in terms of their spectrum of activity and efficacy, there is a risk that such recommendations could result in over-prescribing of broad-spectrum agents with consequent 'collateral damage', meaning superinfection by resistant pathogens, or selection of antibiotic resistance. Narrow-spectrum agents are often as effective and result in less collateral damage. National and local antibiotic guidance should promote choices of agents for narrow-spectrum prescribing even for severe CAP where appropriate.
Original languageEnglish
Pages (from-to)1123-5
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Issue number6
Publication statusPublished - Dec 2009


  • Anti-Bacterial Agents
  • Community-Acquired Infections
  • Drug Resistance, Bacterial
  • Guidelines as Topic
  • Humans
  • Pneumonia


Dive into the research topics of 'Antibiotics for community-acquired pneumonia'. Together they form a unique fingerprint.

Cite this